BXB – UBS rates the stock as Neutral

By Broker News | More Articles by Broker News

Underlying profit was in line with forecasts and the highlight for UBS was the increased price realisation of 3% in response to cost inflation incurred over the past two years.

However, underlying margins still fell in the Americas and EMEA. UBS reduces forecasts for EBIT by -4-5% over the next three years to reflect a higher cost to serve in developed markets.

Neutral rating maintained. Target rises to $12.60 from $12.00.

Sector: Commercial & Professional Services.

Target price is $12.60.Current Price is $13.14. Difference: ($0.54) – (brackets indicate current price is over target). If BXB meets the UBS target it will return approximately -4% (excluding dividends, fees and charges – negative figures indicate an expected loss).

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →